Karen S Lynch
CIK 1333760 · President and CEO · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$18.31M
Companies
9
Total Filings
92
Lifetime Open-Market Net
-$9.73M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TMO | Director | 1,235 | $469.34 | $579.6K | $0 | 8 | 2026-05-22 |
| ADP | Director | 1,535 | $226.21 | $347.2K | $0 | 1 | 2025-11-14 |
| CVS | President and CEO | 74,687 | $101.96 | $7.62M | -$5.03M | 19 | 2024-04-03 |
| USBpR | Director | — | $15.52 | — | $0 | 3 | 2021-12-20 |
| USBpQ | Director | — | $14.80 | — | $0 | 1 | 2020-12-23 |
| USBpP | Director | — | $21.70 | — | $0 | 4 | 2020-04-27 |
| US BANCORP \DE\ (USBpO) Delisted | Director | — | — | — | $0 | 5 | 2018-04-23 |
| MAGELLAN HEALTH INC (MGLN) Delisted | President | 4,896 | $94.99 | $465.1K | -$3.89M | 13 | 2012-03-07 |
| CI | Pres. Grp Ins Dntl Vis & Pharm | 32,770 | $298.00 | $9.77M | -$802.8K | 11 | 2009-06-26 |
Recent Filings · Page 2 of 10
92 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-02-14 | CVS | Grant (A) | +136,640 | $0 | EDGAR |
| 2023-05-05 | CVS | Buy (P) | +14,000 | $976.6K | EDGAR |
| 2023-04-04 | CVS | Mixed | −93,677 | -$6.96M | EDGAR |
| 2023-02-03 | CVS | Grant (A) | +206,610 | $0 | EDGAR |
| 2022-04-05 | CVS | Mixed | −116,940 | -$11.82M | EDGAR |
| 2022-02-23 | CVS | Grant (A) | +257,916 | $0 | EDGAR |
| 2021-12-20 | USBpR | Grant (A) | — | $0 | EDGAR |
| 2021-12-01 | CVS | Tax (F) | −14,121 | -$1.29M | EDGAR |
| 2021-04-28 | USBpR | Grant (A) | — | $0 | EDGAR |
| 2021-04-23 | USBpR | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.